Twenty four hours later, the culture medium was removed and the cells were exposed to fresh medium containing 10% FBS (control) or dilutions of 8-hydroxyquinaldic acid (0.0001; 0.001; 0.05; 0.1; 0.5; 1 mM) and incubated for 96 h in standard conditions. Moreover, 8-hydroxyquinaldic acid inhibited migration of colon cancer HT-29 and LS-180 cells and increased the expression of -catenin and E-cadherin. Importantly, antiproliferative and anti-migratory concentrations of 8-hydroxyquinaldic acid were non-toxic in vitro and in vivo. We reported for the first time antiproliferative and anti-migratory activity of 8-hydroxyquinaldic acid against colon cancer HT-29 and LS-180 cells. < 0.05 (one-way ANOVA with post hoc Tukey test). Open in a separate window Physique 2 The effect of 8-hydroxyquinaldic acid on development (a) and viability (b) of zebrafish larvae. Fertilized zebrafish (AB line) eggs (= 20) were exposed to E3 medium (control, C) or serial dilutions of 8-hydroxyquinaldic acid (0.000001; 0.001; 0.5, 1 mM) in E3 medium for 96 h. The medium was changed every 24 h. The microscopic observations were made in selected time points, i.e., 4, 24, 48, 72, 96 h. To determine the biological effect of 8-hydroxyquinaldic acid on colon cancer cells, several in vitro experiments on human HT-29 and LS-180 colon cancer cells were performed. The effect of 8-hydroxyquinaldic acid on colon cancer cell viability and proliferation was assessed by MTT and BrdU assays, which measure the activity of mitochondrial metabolism and DNA synthesis, respectively. HT-29 and LS-180 cells were exposed either to fresh medium or to 8-hydroxyquinaldic acid (0.0001C1 mM) for 48 h (BrdU assay) or 96 h (MTT assay). 8-Hydroxyquinaldic acid inhibited the viability and mitochondrial metabolism of HT-29 (IC50 = 0.175 mM) and LS-180 (IC50 = 0.349 mM) cells (Figure 3a). Importantly, the inhibitory effect in LS-180 cells was observed in a wide range of concentrations (0.001C1 mM). However, only the highest doses of 8-hydroxyquinaldic acid (0.5C1 mM) decreased DNA synthesis in HT-29 and LS-180 cells up to 90.9% (IC50 = 0.774 mM) and 76.1% Raltitrexed (Tomudex) (IC50 = 0.567 mM), respectively (Figure 3b). Open in a separate window Figure 3 The effect of 8-hydroxyquinaldic acid on proliferation (a) and DNA synthesis (b) of human colon adenocarcinoma cells. HT-29 and LS-180 cells were exposed to Raltitrexed (Tomudex) culture medium (control) or serial dilutions of 8-hydroxyquinaldic acid (0.0001; 0.001; 0.05; 0.1; 0.5; 1 mM) in culture medium. The effect of tested compound LAMB3 on proliferation and metabolic activity of HT-29 and LS-180 cells was assessed by MTT assay after 96 h of incubation (a). The effect of 8-hydroxyquinaldic acid on DNA synthesis of HT-29 and LS-180 cells was assessed by BrdUassay after 48 h of incubation (b). Mean percentage values (% of control) SEM of Raltitrexed (Tomudex) six independent experiments (the mean value of control = 100%) are presented. Values were reported as statistically significant in comparison to the control at * 3. The data were normalized to -actin and calculated fold changes in protein expression marked (fold changes 0.20 were considered as significant [*]). To verify whether 8-hydroxyquinaldic acid has any effect on the migration of colon cancer cells, the ability of HT-29 and LS-180 cells exposed to tested compound to invade the endothelial cell monolayer was analyzed by means of QCM? tumor cell transendothelial migration assay. 8-Hydroxyquinaldic acid in the concentration of 0.5 mM, but not 1 mM, inhibited migration of HT-29 cells (Figure 6). Statistically significant inhibitory effect was also observed in LS-180 cells exposed to 8-hydroxyquinaldic acid (1 mM) (Figure 6). Open in a separate window Figure 6 The effect of 8-hydroxyquinaldic acid on migration of human colon adenocarcinoma cells. The migration of HT-29 Raltitrexed (Tomudex) and LS-180 cells through a monolayer of human umbilical vein endothelial HUVEC cells was assessed byMillipores QCM tumor cell transendothelial cell migration assay. Data represent the OD value (570 nm) SEM of three independent.
Twenty four hours later, the culture medium was removed and the cells were exposed to fresh medium containing 10% FBS (control) or dilutions of 8-hydroxyquinaldic acid (0
Categories
- 34
- 5- Receptors
- A2A Receptors
- ACE
- Acetylcholinesterase
- Adenosine Deaminase
- Adenylyl Cyclase
- Adrenergic ??2 Receptors
- Alpha2 Adrenergic Receptors
- Annexin
- Antibiotics
- ATPase
- AXOR12 Receptor
- Ca2+ Ionophore
- Cannabinoid
- Cannabinoid (GPR55) Receptors
- CB2 Receptors
- CCK Receptors
- Cell Metabolism
- Cell Signaling
- Cholecystokinin2 Receptors
- CK1
- Corticotropin-Releasing Factor1 Receptors
- DHCR
- DMTases
- DNA Ligases
- DNA Methyltransferases
- Dopamine D1 Receptors
- Dopamine D3 Receptors
- Dopamine D4 Receptors
- Endothelin Receptors
- EP1-4 Receptors
- Epigenetics
- Exocytosis & Endocytosis
- Fatty Acid Synthase
- Flt Receptors
- GABAB Receptors
- GIP Receptor
- Glutamate (Kainate) Receptors
- Glutamate (Metabotropic) Group III Receptors
- Glutamate (NMDA) Receptors
- Glutamate Carboxypeptidase II
- Glycogen Phosphorylase
- Glycosyltransferase
- GnRH Receptors
- Heat Shock Protein 90
- hERG Channels
- Hormone-sensitive Lipase
- IKK
- Imidazoline Receptors
- IMPase
- Inositol Phosphatases
- Kisspeptin Receptor
- LTA4 Hydrolase
- M1 Receptors
- Matrixins
- Melastatin Receptors
- mGlu Group III Receptors
- mGlu5 Receptors
- Monoamine Oxidase
- Motilin Receptor
- My Blog
- Neutrophil Elastase
- Nicotinic (??4??2) Receptors
- NKCC Cotransporter
- NMU Receptors
- Nociceptin Receptors
- Non-Selective
- Non-selective 5-HT
- OP3 Receptors
- Opioid, ??-
- Orexin2 Receptors
- Other
- Other Oxygenases/Oxidases
- Other Transcription Factors
- p38 MAPK
- p53
- p56lck
- PAF Receptors
- PDPK1
- PKC
- PLA
- PPAR
- PPAR??
- Proteasome
- PTH Receptors
- Ras
- RNA Polymerase
- Serotonin (5-HT2B) Receptors
- Serotonin Transporters
- Sigma2 Receptors
- Sodium Channels
- Steroid Hormone Receptors
- Tachykinin NK1 Receptors
- Tachykinin NK2 Receptors
- Tachykinin, Non-Selective
- Telomerase
- Thyrotropin-Releasing Hormone Receptors
- Topoisomerase
- trpp
- Uncategorized
- USP
Recent Posts
- 2012) using the Phenotypic Characteristic Search for human strains with markers for resistance to Adamantane, Oseltamivir, or both drugs
- Tissue were homogenized into single-cell suspensions and put through red bloodstream cell lysis
- A phase I/II study investigated the safety and efficacy of concurrent local palliative RT and durvalumab (PD-L1 inhibitor) in 10 patients with unresectable or metastatic advanced solid tumors [136]
- We believe that this hypothesis-generating study could open new avenues for exploring oxidative stress as a potential pathogenetic and, hypothetically, therapeutic target for mitigating CLL strong class=”kwd-title” Keywords: Leukemia, Lymphocytic, Gilbert’s, Syndrome Gilbert’s syndrome (GS) is the most common inherited disorder of bilirubin glucuronidation
- Such costs aren’t simple for tertiary-care hospitals in growing countries sometimes, since these already are powered by minimal budget which switches into provision of fundamental medical services mostly, laboratory, radiology, pharmacy services, and bed space
Tags
a 67 kDa type I transmembrane glycoprotein present on myeloid progenitors
and differentiation. The protein kinase family is one of the largest families of proteins in eukaryotes
Apoptosis
bladder
brain
breast
cell cycle progression
cervix
CSP-B
Cyproterone acetate
EGFR) is the prototype member of the type 1 receptor tyrosine kinases. EGFR overexpression in tumors indicates poor prognosis and is observed in tumors of the head and neck
EM9
endometrium
erythrocytes
F3
Goat polyclonal to IgG H+L)
Goat polyclonal to IgG H+L)Biotin)
GRK4
GSK1904529A
Igf1
Mapkap1
monocytes andgranulocytes. CD33 is absent on lymphocytes
Mouse monoclonal to CD33.CT65 reacts with CD33 andtigen
Palomid 529
platelets
PTK) or serine/threonine
Rabbit Polyclonal to ARNT.
Rabbit polyclonal to BMPR2
Rabbit Polyclonal to CCBP2.
Rabbit Polyclonal to EDG4
Rabbit polyclonal to EIF4E.
Rabbit polyclonal to IL11RA
Rabbit polyclonal to LRRIQ3
Rabbit Polyclonal to MCM3 phospho-Thr722)
Rabbit Polyclonal to RBM34
SB 216763
SKI-606
SNX-5422
STK) kinase catalytic domains. Epidermal Growth factor receptor
stomach
stomach and in squamous cell carcinoma.
TNFSF8
TSHR
VEGFA
vulva